AHPA on USP ingredient information
This article was originally published in The Tan Sheet
Executive SummaryThe American Herbal Products Association asks U.S. Pharmacopoeia to "refrain from requiring cautionary statements" on "USP-quality black cohosh and USP powdered decaffeinated green tea extract" in its newly adopted ingredient safety classification system. Instead, AHPA suggests USP use a safety information section in supplement ingredient monographs to present findings from DSI-EC. This would allow manufacturers "to intelligently apply the findings of the DSI-EC as is appropriate on a product-by-product basis," the group says. The current system adopted by USP classifies ingredients into three categories: Class 1, (safe with no labeling statement), Class 2 (safe with suitable labeling statement) and Class 3 (not safe)...
You may also be interested in...
Japan bioventure BioComo was set up around 10 years ago and has since been honing its technology platform. It is now preparing to move into the clinic with a novel vector for immuno-oncology and to raise new funds to support pipeline development.
Several newly repurposed drugs, including a Bayer antimalarial, have shown potential benefits against the new coronavirus, promoting China to add several to its latest revised treatment guidelines.
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.